⌘K

Login Start Free

Home/Filings/4/0001213900-22-075490

4//SEC Filing

Marques Tiago 4

Accession 0001213900-22-075490

CIK 0001841330other

View on SEC.gov Company Profile

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 4:00 PM ET

Size

8.8 KB

Accession

0001213900-22-075490

Insider Transaction Report

Form 4

Period: 2022-11-23

Pasithea Therapeutics Corp.KTTA

DirectorChief Executive Officer

Transactions

Award
Common Stock
2022-11-23$1.00/sh+5,000$5,000→ 815,000 total
Award
Common Stock
2022-11-25$1.03/sh+2,000$2,060→ 819,206 total
Award
Common Stock
2022-11-23$1.03/sh+1,000$1,030→ 816,000 total
Award
Common Stock
2022-11-23$1.02/sh+1,206$1,230→ 817,206 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Pasithea Therapeutics Corp.

CIK 0001841330

Entity typeother

Related Parties

1

filerCIK 0001875240

Filing Metadata

Form type: 4
Filed: Nov 27, 7:00 PM ET
Accepted: Nov 28, 4:00 PM ET
Size: 8.8 KB

View on SEC.gov